Beryl Drugs Limited (BOM:524606)

India · Delayed Price · Currency is INR

24.95

+0.36 (1.46%)

At close: Sep 7, 2026

Market Cap	124.71M +2.0%
Revenue (ttm)	213.23M +8.3%
Net Income	6.25M +169.1%
EPS	n/a
Shares Out	5.07M
PE Ratio	19.97
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,695
Open	22.60
Previous Close	24.59
Day's Range	22.60 - 25.19
52-Week Range	15.92 - 27.60
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Beryl Drugs

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India. [Read more]

Industry Pharmaceutical Preparations

Founded 1993

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524606

Full Company Profile

Financial Performance

In fiscal year 2026, Beryl Drugs's revenue was 188.20 million, a decrease of -11.00% compared to the previous year's 211.46 million. Earnings were 4.25 million, a decrease of -26.61%.

Financial Statements